COCRYSTAL PHARMA, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- COCRYSTAL PHARMA, INC. stock issued during period, value, stock options exercised for the quarter ending 2018-12-31 was $43.00K.
- COCRYSTAL PHARMA, INC. stock issued during period, value, stock options exercised for the quarter ending 2018-09-30 was $0.00.
- COCRYSTAL PHARMA, INC. stock issued during period, value, stock options exercised for the quarter ending 2018-06-30 was $1.00K.
- COCRYSTAL PHARMA, INC. stock issued during period, value, stock options exercised for the quarter ending 2018-03-31 was $184.00K.
- COCRYSTAL PHARMA, INC. stock issued during period, value, stock options exercised for fiscal 2018 was $228.00K, a 185.00% increase from fiscal 2017.
- COCRYSTAL PHARMA, INC. stock issued during period, value, stock options exercised for fiscal 2017 was $80.00K, a 2566.67% increase from fiscal 2016.
- COCRYSTAL PHARMA, INC. stock issued during period, value, stock options exercised for fiscal 2016 was $3.00K, a 86.96% decline from fiscal 2015.
- COCRYSTAL PHARMA, INC. stock issued during period, value, stock options exercised for fiscal 2015 was $23.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2018-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $228.00K 10-K · filed 2020-03-27 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $185.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $1.00K 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $184.00K 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $80.00K 10-K · filed 2019-04-01 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $3.00K 10-K · filed 2018-03-21 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | |
| 2016-06-30 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | |
| 2016-03-31 | $35.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $23.00K 10-K · filed 2018-03-21 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 | |
| 2013-12-31 | $7.00K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |